Welcome : Guest

INSULIN PUMPS (EXTERNAL) - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Insulin Pumps (External) in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 15 companies including many key and niche players such as -

Animas Corp.
Debiotech S.A.
F. Hoffmann-La Roche, Ltd.
Insulet Corp.
Medtronic Plc

Click here to request a full list of companies covered in the report...

Code: MCP-1511
Price: $4950
Companies: 15
Pages: 179
Date: November 2016
Market Data Tables: 52
  Status: * New Report



TABLE OF CONTENTS


  INSULIN PUMPS (EXTERNAL) (Complete Report) Pages : 179   | $4950

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Insulin Pumps: A Prelude.....II-11$100
   The United States – The Largest Market.....II-21$100
   Europe – A Market with Vast Potential.....II-3
Lower Current Penetration Leaves Significant Room for Growth.....II-3
1$100
   Table 1: Insulin Pumps Market by Region (2013): Percentage Breakdown of Number of Users of Insulin Pumps for Established Markets and Rest of World (includes corresponding Graph/Chart).....II-4

Table 2: Insulin Pump Penetration Rate in Type 1 Diabetic Patients by Country (2013): Number of Users as a Share of Population for Select Leading Countries (includes corresponding Graph/Chart).....II-4
Rising Incidence of Diabetes – A Major Market Driving Factor.....II-4
2$700
   Table 3: Global Diabetic Population by Region (2015 & 2040) (includes corresponding Graph/Chart).....II-61$350
   Table 4: Top Ten Diabetic Countries by Number of Individuals with Diabetes for 2015 (includes corresponding Graph/Chart).....II-7

Table 5: Top Ten Diabetic Countries by Number of Individuals with Diabetes for 2040 (includes corresponding Graph/Chart).....II-7
1$350
   Diabetes – Assessing the Economic Burden.....II-8
Table 6: Diabetes Related Healthcare Expenditure by Region: 2015 & 2040 (in US$ Billion) (includes corresponding Graph/Chart).....II-8
1$350
   Table 7: Major Spenders on Diabetes (2015): Annual Expenditure on Diabetes Treatment and Management in US$ Billion for Ten Leading Countries (includes corresponding Graph/Chart).....II-91$350
   Insulin Pumps Market – Set for Interesting Road Ahead.....II-10 1$100
   Table 8: Leading Players in the Global Market for External Insulin Pumps (2015E): Percentage Breakdown of Value Sales for Insulet, J&J (Animas), Medtronic, Roche, Tandem and Others (includes corresponding Graph/Chart).....II-11
Comparison of Select Durable Insulin Pumps by Manufacturer.....II-11
1$350
   Medtronic Banks on New Solutions and Distribution Expansion to Retain
  Dominance.....II-12
J&J’s OneTouch Via – A Discrete Solution for On-Demand Insulin.....II-12
1$100
   Tandem Sees Gradual Rise in Market Share.....II-13
Ypsomed Eyes Brighter Prospects with YpsoPump.....II-13
1$100
   Medtrum – A New Entrant with a Strong Product; Threatening to Take the Market by
  Storm.....II-14
1$100
   Competitive Landscape in the Insulin Patch Pump Market.....II-15
OmniPod Benefits from Lack of Close Competition in its League.....II-15
Insulet Focuses on Advances in Technology and Services to Gain Market Share.....II-15
1$100
   Cellnovo’s Patch Pump Combines Functionality and Cost-Effectiveness.....II-161$100
   V-Go – An Affordable Patch Pump for Type II Diabetics.....II-17
Valeritas Struggles to Push Sales of V-Go.....II-17
1$100
   Tough Ground for New Entrants.....II-181$100
   Type II Diabetes – A Market with Significant Potential.....II-19
Patch Pumps Gain Manufacturer Attention.....II-19
1$100
   Prefilled Insulin Cartridges Gain Popularity over Manual Filling.....II-20
The Rise of Smart Pumps – A Major Game Changer.....II-20
1$100
   Innovative Features Spruce Up the Market for Insulin Pumps.....II-21
Artificial Pancreas System (APS) – The Future of Diabetes Care.....II-21
1$100
   Artificial Pancreas – Are We There Yet?.....II-22
The Risk of Diabetes in Aging Populace Presents Opportunities for Insulin
  Pumps.....II-22
1$100
   Table 9: Percentage Growth of 65+ Population in North America, Europe, Asia, and Latin America (includes corresponding Graph/Chart).....II-231$350
   Table 10: Global Population Statistics for the 65+ Age Group (2015) (includes corresponding Graph/Chart).....II-241$350
   Table 11: Comparison of Aging Population by Country (1980, 2015 & 2050): Percentage Share of Population Aged Above-65 Years of the Overall Population for Select Countries (includes corresponding Graph/Chart).....II-251$350
   Table 12: Life Expectancy for Select Countries in Number of Years: 2015E (includes corresponding Graph/Chart).....II-26
Alarming Rise in Obesity – A Business Case for Diabetes Care.....II-26
1$350
   Table 13: World Obesity Prevalence (2015 & 2022): Percentage of Obese Population for Leading Ten Countries (includes corresponding Graph/Chart).....II-271$350
   Diabetes in Developing Countries to Expand Opportunities.....II-281$100
   ICR: A Key Factor to Success.....II-29
Customer Satisfaction: Crucial to Stay Competitive.....II-29
Expiry of Warranty Provides New Opportunities to Insulin Pump Makers.....II-29
Undiagnosed Diabetes – A Key Challenge.....II-29
1$100
   Better Safety Review – A Growing Need for Insulin Pumps.....II-30
Insulin Pump Training - Not Receiving Adequate Attention.....II-30
Complicated Insulin Pump Software Makes Pump Use Difficult for the Aged.....II-30
1$100
   Competition from Other Insulin Delivery Technologies Continues.....II-31
Implantable Insulin Pumps – A Potential Threat to External Insulin Pumps.....II-31
1$100
   Lantus: A Threat to Insulin Pump Manufacturers.....II-321$100
   Diabetes - A Fatal Disease.....II-33
Risk Factors for Diabetes.....II-33
Types of Diabetes.....II-33
1$100
   Long Term Complications of Diabetes.....II-34
Testing Sugar Levels: Easy and Accurate.....II-34
Insulin.....II-34
Pancreas: The Main Source of Insulin in Human Body.....II-34
1$100
   Types of Insulin.....II-35
Types of Insulin & Onset of Action.....II-35
Goal of Insulin Therapy.....II-35
Insulin Delivery Systems.....II-35
1$100
   a. Syringes.....II-361$100
   b. Insulin Pens.....II-37
c. Jet Injectors.....II-37
d. Tablets.....II-37
e. External Insulin Pumps.....II-37
1$100
   f. Artificial Pancreas.....II-38
Insulin Delivery Technologies.....II-38
1$100
   Evolution of Insulin Pumps.....II-39
Components of Insulin Pump.....II-39
1$100
   How Does an Insulin Pump Work?.....II-40
Value-added Features of Modern Insulin Pumps.....II-40
Bolus Calculators.....II-40
Insulin on Board.....II-40
Customized Alarms.....II-40
1$100
   Touch Bolus.....II-41
Interface to PCs.....II-41
Others.....II-41
Insulin Pump Delivery Rates.....II-41
Guidelines for Insulin Pump Usage.....II-41
1$100
   Advantages.....II-42
More Accurate and Consistent.....II-42
Enhances Blood Sugar Control in Pediatric Patients.....II-42
1$100
   Adjusting Time Zones While Traveling.....II-43
Improves Quality of Life.....II-43
Patient Convenience.....II-43
Other Advantages.....II-43
1$100
   Disadvantages/Risks Involved in the Usage of Insulin Pumps.....II-44
High Cost.....II-44
High Involvement.....II-44
Diabetic Ketoacidosis Risk.....II-44
Glucose Testing at Regular Intervals.....II-44
Regular Rotation of Infusion Set.....II-44
1$100
   Carrying Back-up Kit.....II-45
Regular Refilling of Pump.....II-45
Other Disadvantages.....II-45
1$100
   Cellnovo Files FDA 510(k) Clearance for Diabetes Management System.....II-46
Medtronic Obtains FDA Nod for its New MiniMed® 670G System.....II-46
Medtrum Launches Medtrum P6 Tubeless Insulin Pump.....II-46
Medtronic Launches MiniMed® 630G System.....II-46
Tandem Secures FDA Expanded Indication for t:slim® Insulin Pump.....II-46
EMA Clears Use of mylife™ YpsoPump® with NovoRapid® PumpCart®.....II-46
Animas Receives FDA Expanded Indication for Animas® Vibe® Insulin Pump in
  Children.....II-46
1$100
   Medtronic Introduces MiniMed Connect System for Insulin Pumps and CGMs.....II-47
Tandem Gets FDA Nod for t:slim G4 Insulin Pump.....II-47
Unilife Rolls Out Instant Patch Pumps Platform - Imperium™.....II-47
Medtronic Rolls Out MiniMed™ 640G System.....II-47
Tandem Bags FDA Clearance for t:flex Insulin Pump.....II-47
Roche Rolls Out Accu-Chek Insight Insulin Pump System in the UK.....II-47
J&J Animas Obtains FDA Approval for Vibe Insulin Pump.....II-47
1$100
   Novo Nordisk Launches NovoRapid® PumpCart® Prefilled Cartridge.....II-48
Medtronic Introduces Arabic-Enabled Insulin Pump.....II-48
Medtronic Launches MiniMed® Duo™ in Europe.....II-48
Animas Secures CE Mark for Animas® Vibe™ Insulin Pump.....II-48
Cellnovo Introduces Novel Insulin Pump System in the UK.....II-48
Debiotech to Unveil JewelPump2.....II-48
J&J Introduces Animas Vibe in Canada.....II-48
1$100
   Tandem Announces Order Intake for t:slim X2™ Insulin Pump.....II-49
Bigfoot Secure FDA’s Clearance for Artificial Pancreas Trial.....II-49
Tandem Inks Technology Licensing Deal with TypeZero.....II-49
Ypsomed and Novo Nordisk Sign Pact for mylife™ YpsoPump®.....II-49
UnitedHealth Group Selects Medtronic As Exclusive Supplier of Insulin Pumps.....II-49
Cellnovo and Roche Enter into Commercial Agreement for BGM.....II-49
1$100
   Insulet Inks Deal with Mode for Licensing Artificial Pancreas Algorithm.....II-50
Ypsomed Expands Availability of mylife™ OmniPod® in Europe.....II-50
Medtronic Enters into Agreement with Chengdu Government to Produce Insulin
  Pumps.....II-50
Insulet and Eli Lilly Team Up to Develop New Version of OmniPod for Delivering Lilly's
  Humalog.....II-50
Tandem and Dexcom Ink Deal to Pair their Devices.....II-50
BD Medical and Medtronic Collaborate to Launch New Infusion Set.....II-50
Bigfoot Biomedical Takes Over Asante Solutions.....II-50
1$100
   Debiotech to Take Over Rights to iSense CGM.....II-51
Medtronic Acquires Covidien.....II-51
1$100
   Animas Corp. (USA).....II-52
Debiotech S.A. (Switzerland).....II-52
F. Hoffmann-La Roche, Ltd. (Switzerland).....II-52
1$100
   Insulet Corp. (USA).....II-53
Medtronic Plc. (Ireland).....II-53
1$100
   Sooil Development Co. Ltd. (Korea).....II-54
Tandem Diabetes Care Inc. (USA).....II-54
1$100
   Valeritas Inc. (US).....II-55
Ypsomed Holding AG (Switzerland).....II-55
1$100
   Table 14: World Recent Past, Current & Future Analysis for Insulin Pumps (External) by Geographic Region - US, Canada, Europe, Asia-Pacific (Including Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-561$350
   Table 15: World Historic Review for Insulin Pumps (External) by Geographic Region - US, Canada, Europe, Asia-Pacific (Including Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-571$350
   Table 16: World 14-Year Perspective for Insulin Pumps (External) by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Europe, Asia-Pacific (Including Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-581$350
   A. Market Analysis.....III-1
Current & Future Analysis.....III-1
Table 17: Prevalence of Diabetes Mellitus in the US (2013 & 2035): Number of People with DM (in Thousands) in the 20-79 Age Group (includes corresponding Graph/Chart).....III-1
1$200
   Table 18: The US Diabetics Population (2010-2017): Percentage Population with Diagnosed and Undiagnosed Diabetes (includes corresponding Graph/Chart).....III-21$200
   Table 19: US Market for Diabetes Management (2015 & 2018P): Percentage Share Breakdown by Treatment Type (includes corresponding Graph/Chart).....III-3

Table 20: Diabetes Prevalence by Ethnicity (includes corresponding Graph/Chart).....III-3
Increasing Inclination towards Patch Pumps.....III-3
1$200
   Artificial Pancreas System (APS): The Future of Diabetes Management.....III-4
Select Clinical Studies on Artificial Pancreas Technology.....III-4
Competitive Scenario.....III-4
1$75
   Table 21: Leading Players in the US Insulin Pump Market (2014): Percentage Breakdown of Installed Base by Company (includes corresponding Graph/Chart).....III-5
Comparison of Select Insulin Pump Systems Available in the US.....III-5
Reimbursements.....III-5
1$200
   Regulatory Scenario.....III-6
FDA Announces a New Mandate for Manufacturing Companies.....III-6
Product Approvals/Launches.....III-6
2$150
   Strategic Corporate Developments.....III-81$75
   Select Key Players.....III-92$150
   B. Market Analytics.....III-11
Table 22: The US Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-11
1$200
   Table 23: The US Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-121$200
   A. Market Analysis.....III-13
Current & Future Analysis.....III-13
Diabetes Statistics.....III-13
Table 24: Prevalence of Adult Diabetes in Canada by Gender (2010-2014): Number of Adult Males and Females Aged 12 Years and Over Diagnosed with Diabetes (In Thousands) (includes corresponding Graph/Chart).....III-13
1$200
   Table 25: Prevalence of Adult Diabetes in Canada by Age Group (2010-2014): Number of Adult Males and Females with Diabetes by Age Group (In Thousands) (includes corresponding Graph/Chart).....III-14
Product Launch.....III-14
1$200
   B. Market Analytics.....III-15
Table 26: Canadian Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-15
1$200
   Table 27: Canadian Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-161$200
   A. Market Analysis.....III-17
Current & Future Analysis.....III-17
Market Overview.....III-17
1$75
   Regional Scenario.....III-18
Diabetes Prevalence in Europe.....III-18
1$75
   Table 28: Diabetes Prevalence in Europe (2015): Prevalence of Type I & Type II Diabetes As Percentage of Adult Population (Aged 20 to 79 Years) by Country (includes corresponding Graph/Chart).....III-191$200
   Product Approvals.....III-201$75
   B. Market Analytics.....III-21
Table 29: European Recent Past, Current & Future Analysis for Insulin Pumps (External) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-21
1$200
   Table 30: European Historic Review for Insulin Pumps (External) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-221$200
   Table 31: European 14-Year Perspective for Insulin Pumps (External) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-231$200
   A. Market Analysis.....III-24
Current & Future Analysis.....III-24
Strategic Corporate Development.....III-24
1$75
   B. Market Analytics.....III-25
Table 32: French Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-25
1$200
   Table 33: French Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-261$200
   Market Analysis.....III-27
Table 34: German Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-27
1$200
   Table 35: German Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-281$200
   Market Analysis.....III-29
Table 36: Italian Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-29
1$200
   Table 37: Italian Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-301$200
   A. Market Analysis.....III-31
Current & Future Analysis.....III-31
INPUT (The Insulin Pump Therapy Group).....III-31
NICE (National Institute of Clinical Excellence).....III-31
1$75
   Product Launches.....III-321$75
   B. Market Analytics.....III-33
Table 38: The UK Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-33
1$200
   Table 39: The UK Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-341$200
   Market Analysis.....III-35
Table 40: Spanish Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-35
1$200
   Table 41: Spanish Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-361$200
   Market Analysis.....III-37
Table 42: Russian Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-37
1$200
   Table 43: Russian Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-381$200
   A. Market Analysis.....III-39
Current & Future Analysis.....III-39
Diabetes in Russia.....III-39
Product Launches.....III-39
1$75
   Strategic Corporate Developments.....III-40
Select Key Players.....III-40
3$225
   B. Market Analytics.....III-43
Table 44: Rest of European Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-43
1$200
   Table 45: Rest of European Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-441$200
   A. Market Analysis.....III-45
Current & Future Analysis.....III-45
Table 46: Diabetes in Asia-Pacific (2015): Number of People with Diabetes for Select Countries (includes corresponding Graph/Chart).....III-45
1$200
   Review of Select Markets.....III-46
China.....III-46
Overview.....III-46
China: An Untapped Goldmine.....III-46
India.....III-46
Diabetes Scenario.....III-46
1$75
   Insulin Pumps Market in India – An Overview.....III-47
New Indigenously Developed Product Could be the Answer.....III-47
Medtronic: The Current Market Leader.....III-47
1$75
   Diabetic Epidemic Spurs Indian Market.....III-48
Strategic Corporate Development.....III-48
1$75
   Key Player.....III-49
B. Market Analytics.....III-49
Table 47: Asia-Pacific Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-49
1$200
   Table 48: Asia-Pacific Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-501$200
   A. Market Analysis.....III-51
Current & Future Analysis.....III-51
A Peek in to the Brazilian Insulin Pumps Market.....III-51
1$75
   B. Market Analytics.....III-52
Table 49: Latin American Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-52
1$200
   Table 50: Latin American Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-531$200
   A. Market Analysis.....III-54
Current & Future Analysis.....III-54
Demand for Insulin Pumps Surges in the UAE.....III-54
B. Market Analytics.....III-54
Table 51: Rest of World Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-54
1$200
   Table 52: Rest of World Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-551$200
  
Total Companies Profiled: 18 (including Divisions/Subsidiaries - 15)

Region/Country Players

The United States 11 Europe 6 France 1 The United Kingdom 1 Rest of Europe 4 Asia-Pacific (Excluding Japan) 1
Click here to request a full table of contents and more details on this project.